Cargando…
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986165/ https://www.ncbi.nlm.nih.gov/pubmed/35397229 http://dx.doi.org/10.1016/S2468-1253(22)00120-0 |
| _version_ | 1784682491601223680 |
|---|---|
| author | Wellens, Judith Brann, Stephanie Adams, Alex Marlow, Luke Lindsay, James O Satsangi, Jack J |
| author_facet | Wellens, Judith Brann, Stephanie Adams, Alex Marlow, Luke Lindsay, James O Satsangi, Jack J |
| author_sort | Wellens, Judith |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8986165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89861652022-04-07 Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease Wellens, Judith Brann, Stephanie Adams, Alex Marlow, Luke Lindsay, James O Satsangi, Jack J Lancet Gastroenterol Hepatol Correspondence Elsevier Ltd. 2022-06 2022-04-06 /pmc/articles/PMC8986165/ /pubmed/35397229 http://dx.doi.org/10.1016/S2468-1253(22)00120-0 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Wellens, Judith Brann, Stephanie Adams, Alex Marlow, Luke Lindsay, James O Satsangi, Jack J Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title | Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title_full | Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title_fullStr | Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title_full_unstemmed | Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title_short | Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease |
| title_sort | determinants of uptake of a third dose of sars-cov-2 vaccines in patients with inflammatory bowel disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986165/ https://www.ncbi.nlm.nih.gov/pubmed/35397229 http://dx.doi.org/10.1016/S2468-1253(22)00120-0 |
| work_keys_str_mv | AT wellensjudith determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease AT brannstephanie determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease AT adamsalex determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease AT marlowluke determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease AT lindsayjameso determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease AT satsangijackj determinantsofuptakeofathirddoseofsarscov2vaccinesinpatientswithinflammatoryboweldisease |